Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer
- PMID: 30390770
- DOI: 10.1016/j.hoc.2018.07.006
Targeting DNA Damage Response and Repair as a Therapeutic Strategy for Ovarian Cancer
V体育安卓版 - Abstract
Large-scale genomic studies have demonstrated that ovarian cancer is characterized by frequent genetic and epigenetic alterations of gene members of the homologous recombination repair pathway VSports手机版. Homologous recombination repair deficiency induces genomic instability and hyperdependence on alternative DNA repair mechanisms, and is associated with enhanced sensitivity to double-strand break-inducing agents such as platinum analogues and poly(adenosine diphosphate)-ribose polymerase inhibitors. The authors review the DNA repair pathway alterations that are present in ovarian cancer, and discuss current and emerging therapeutic approaches that target the DNA damage response and repair focusing on chemotherapy and poly(adenosine diphosphate)-ribose polymerase inhibitors. .
Keywords: DNA repair deficiency; Homologous recombination deficiency; Ovarian cancer; PARP-inhibitors; Platinum agents. V体育安卓版.
Copyright © 2018 Elsevier Inc. All rights reserved. V体育ios版.
Publication types
- "VSports手机版" Actions
- Actions (V体育ios版)
MeSH terms
- "VSports app下载" Actions
- V体育官网 - Actions
- V体育安卓版 - Actions
- V体育官网 - Actions
Substances
- "VSports注册入口" Actions
"V体育官网" LinkOut - more resources
Full Text Sources
Medical